鼻内胰岛素给药对老年心脏手术患者术后谵妄预防效果:多中心、双盲、随机对照试验研究方案
本研究为多中心、双盲、随机对照试验,计划于2023年7月1日至2025年12月31日在日本筑波大学医院和筑波医学中心医院纳入110例65岁及以上接受体外循环心脏手术的老年患者,随机分为鼻内胰岛素组与鼻内生理盐水组,主要结局为术后7天内谵妄发生率。
要点
- 术后谵妄总体发生率约10-25%,心脏手术后可达50%。
- 认知功能障碍及谵妄患者鼻内给予最多160单位胰岛素可改善记忆功能及脑代谢,且未出现低血糖等并发症。
- 本研究旨在评估术中80 IU鼻内胰岛素给药能否预防体外循环心脏手术后谵妄。
核心结论
- 本研究旨在评估术中80 IU鼻内胰岛素给药能否预防体外循环心脏手术后术后谵妄。
- 研究结果可能为需体外循环心脏手术患者预防术后谵妄提供策略选择。
研究设计与样本
- 多中心、双盲、随机对照试验,在筑波大学医院和筑波医学中心医院开展。
- 研究时间为2023年7月1日至2025年12月31日。
- 计划纳入110例65岁及以上接受需体外循环心脏手术的老年患者,随机分配至鼻内胰岛素组或鼻内生理盐水组。
主要发现
- 主要结局为术后7天内术后谵妄发生率。
- 次要结局包括谵妄天数和次数、认知功能筛查测试、疼痛评分、术后气管插管时长及ICU住院时长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative delirium (POD) is a complication after surgery which leads to worse outcomes. The frequency of this syndrome is increasing as more elderly patients undergo major surgery. The frequency is around 10-25% but reaches as high as 50% for cardiac surgery. Although intranasal insulin (INI) administration of up to 160 units in patients with cognitive dysfunction and delirium has been shown to improve memory function and brain metabolism without complications such as hypoglycemia, it remains unknown whether INI prevents POD after cardiac surgery METHODS: A multicenter, double-blind, randomized, controlled trial will be conducted at University of Tsukuba Hospital and Tsukuba Medical Center Hospital, Japan, from July 1, 2023, to December 31, 2025. A total of 110 elderly patients (65 years old or older) undergoing cardiac surgery requiring cardiopulmonary bypass will be enrolled and randomly allocated to intranasal insulin or intranasal saline groups. The primary outcome is the incidence of POD within 7 days after surgery. Secondary outcomes include days and times of delirium, screening tests of cognitive function, pain scores, duration of postoperative tracheal intubation, and length of ICU stay. DISCUSSION: The present objective is to assess whether 80 IU INI administration during surgery prevents POD after cardiac surgery. The results may provide strategic choices to prevent POD in patients with cardiac surgery requiring cardiopulmonary bypass. TRIAL REGISTRATION: The trial was registered with the Japan Registry for Clinical Trials with identifier jRCTs031230047 on April 21, 2023.
引用
- Nakadate Y, Yamada M, Kusuyama N, et al. Effect of intranasal insulin administration on postoperative delirium prevention in elderly cardiac surgery patients: study protocol for a multicenter, double-blind, randomized, controlled trial. Trials. 2023. PMID: 38129907. doi:10.1186/s13063-023-07860-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。